Literature DB >> 27727072

Association Between Serum Cystatin C Level and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients With Acute Lacunar Stroke.

Song Yang1, Jing Cai2, Rulan Lu3, Jian Wu1, Min Zhang3, Xianju Zhou4.   

Abstract

OBJECTIVE: Chronic kidney disease (CKD) is associated with cerebral small vessel disease (cSVD). However, the relationship between serum cystatin C (CysC) level, a highly sensitive marker of impaired kidney function, and cSVD has not been fully understood. This study aimed to investigate the association between serum CysC level and total burden of cSVD on magnetic resonance imaging (MRI) in patients with acute lacunar stroke.
MATERIALS AND METHODS: A total of 210 patients with first-ever acute lacunar stroke occurring within 1 week after onset were included in this study. Serum CysC level, decreased estimated glomerular filtration rate (eGFR), and proteinuria were used to evaluate kidney function. The combined effect of the markers of cSVD on MRI, including lacunar, white matter lesions, cerebral microbleeds, and enlarged perivascular spaces, were used to evaluate the comprehensive cSVD burden.
RESULTS: There is a positive association between total cSVD burden and hypertension, low eGFR level, and serum CysC level. After adjustments for potential confounders by ordinal logistic regression, elevated levels of CysC as well as impaired eGFR and the presence of proteinuria were correlated with the burden of total cSVD (odds ratio [OR] 2.633, 95% confidence interval [CI] 1.284-5.403; OR 2.442, 95% CI 1.213-4.918; and OR 2.151, 95% CI 1.162-3.983, respectively).
CONCLUSIONS: The elevated level of serum CysC is associated with the total burden of cSVD in patients with acute lacunar stroke independent of conventional risk factors.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Serum cystatin C; acute lacunar stroke; cerebral microbleeds; cerebral small vessel disease; chronic kidney disease; enlarged perivascular spaces; total MRI burden; white matter lesions

Mesh:

Substances:

Year:  2016        PMID: 27727072     DOI: 10.1016/j.jstrokecerebrovasdis.2016.09.007

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  12 in total

1.  Expression and significance of S-100β, CysC and NF-κB in patients with acute cerebral infarction.

Authors:  Zaili Li; Zaie Xin
Journal:  Exp Ther Med       Date:  2020-12-16       Impact factor: 2.447

2.  Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurotox Res       Date:  2019-07-02       Impact factor: 3.911

3.  Association between Cystatin C and SVD in Chinese population.

Authors:  Huang Guoxiang; Lu Hui; Zhou Yong; Ji Xunming; Chen Zhuo
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

4.  Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway.

Authors:  Guangna Yu; Xingyuan Sun; Li Li; Lijuan Huang; Hongbin Liu; Shuying Wang; Zhanjun Ren; Yanjiao Zhang
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

Review 5.  Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment.

Authors:  Beida Ren; Ling Tan; Yuebo Song; Danxi Li; Bingjie Xue; Xinxing Lai; Ying Gao
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

6.  Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression.

Authors:  Woo-Jin Lee; Keun-Hwa Jung; Young Jin Ryu; Jeong-Min Kim; Soon-Tae Lee; Kon Chu; Manho Kim; Sang Kun Lee; Jae-Kyu Roh
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

7.  Twenty-four-hour ambulatory blood pressure variability is associated with total magnetic resonance imaging burden of cerebral small-vessel disease.

Authors:  Shuna Yang; Junliang Yuan; Wei Qin; Lei Yang; Huimin Fan; Yue Li; Wenli Hu
Journal:  Clin Interv Aging       Date:  2018-08-10       Impact factor: 4.458

Review 8.  Cerebral Small Vessel Disease.

Authors:  Jakub Litak; Marek Mazurek; Bartłomiej Kulesza; Paweł Szmygin; Joanna Litak; Piotr Kamieniak; Cezary Grochowski
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

9.  Association of Renal Dysfunction With Remote Diffusion-Weighted Imaging Lesions and Total Burden of Cerebral Small Vessel Disease in Patients With Primary Intracerebral Hemorrhage.

Authors:  Xu-Hua Xu; Xiang-Hua Ye; Jin-Song Cai; Ting Gao; Guo-Hua Zhao; Wen-Ji Zhang; Lu-Sha Tong; Feng Gao
Journal:  Front Aging Neurosci       Date:  2018-06-07       Impact factor: 5.750

10.  Early renal dysfunction and fibroblast growth factor-23 in patients with small vessel disease-related stroke.

Authors:  Simon Fandler-Höfler; Christian Enzinger; Markus Kneihsl; Daniela Pinter; Sebastian Eppinger; Barbara Obermayer-Pietsch; Anna Goritschan; Hildegard Hafner-Giessauf; Alexander R Rosenkranz; Franz Fazekas; Thomas Gattringer
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.